A detailed history of Heritage Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Heritage Financial Services, LLC holds 3,393 shares of ABBV stock, worth $575,554. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,393
Previous 3,043 11.5%
Holding current value
$575,554
Previous $521,000 28.6%
% of portfolio
0.09%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $57,344 - $69,765
350 Added 11.5%
3,393 $670,000
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $10,680 - $12,472
-69 Reduced 2.22%
3,043 $521,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $7,511 - $8,558
-47 Reduced 1.49%
3,112 $566,000
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $31,372 - $35,333
228 Added 7.78%
3,159 $489,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $28,721 - $33,249
215 Added 7.92%
2,931 $436,000
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $5,035 - $6,266
38 Added 1.42%
2,716 $365,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $19,233 - $22,149
-133 Reduced 4.73%
2,678 $426,000
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $80,496 - $96,536
582 Added 26.11%
2,811 $0
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $16,239 - $18,625
121 Added 5.74%
2,229 $299,000
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $67,296 - $85,555
-489 Reduced 18.83%
2,108 $322,000
Q1 2022

Aug 30, 2022

BUY
$131.98 - $163.75 $52,132 - $64,681
395 Added 17.94%
2,597 $420,000
Q4 2021

Aug 26, 2022

BUY
$107.43 - $135.93 $236,560 - $299,317
2,202 New
2,202 $298,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Heritage Financial Services, LLC Portfolio

Follow Heritage Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Financial Services, LLC with notifications on news.